Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Aug 16;9(8):887.
doi: 10.3390/nu9080887.

The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection

Myeong Soo Park  1 , Bin Kwon  2 , Seockmo Ku  3 , Geun Eog Ji  4   5
Affiliations
Randomized Controlled Trial

The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection

Myeong Soo Park et al. Nutrients. .

Abstract

A total of 57 infants hospitalized with rotavirus disease were included in this study. The children were randomly divided into the study's two treatment groups: three days of the oral administration of (i) a probiotics formula containing both Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 (N = 28); or (ii) a placebo (probiotic-free skim milk, N = 29) and the standard therapy for diarrhea. There were no differences in age, sex, or blood characteristics between the two groups. When the 57 cases completed the protocol, the duration of the patients' diarrhea was significantly shorter in the probiotics group (4.38 ± 1.29, N = 28) than the placebo group (5.61 ± 1.23, N = 29), with a p-value of 0.001. Symptoms such as duration of fever (p = 0.119), frequency of diarrhea (p = 0.119), and frequency of vomiting (p = 0.331) tended to be ameliorated by the probiotic treatment; however, differences were not statistically significant between the two groups. There were no serious, adverse events and no differences in the frequency of adverse events in both groups.

Keywords: Bifidobacterium; Lactobacillus; probiotics; rotavirus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Lanata C., Fischer-Walker C., Olascoaga A., Torres C., Aryee M., Black R. Global Causes of Diarrheal Disease Mortality in Children <5 Years Of Age: A Systematic Review. PLoS ONE. 2013;8:e72788. - PMC - PubMed
    1. Youssef M., Shurman A., Bougnoux M., Rawashdeh M., Bretagne S., Strockbine N. Bacterial, Viral and Parasitic Enteric Pathogens Associated with Acute Diarrhea in Hospitalized Children from Northern Jordan. FEMS Immunol. Med. Microbiol. 2000;28:257–263. doi: 10.1111/j.1574-695X.2000.tb01485.x. - DOI - PubMed
    1. Vaccine Information Statement|Rotavirus|VIS|CDC. [(accessed on 26 June 2017)]; Available online: https://www.cdc.gov/vaccines/hcp/vis/vis-statements/rotavirus.html.
    1. Bernstein D. Rotavirus Overview. Pediatr. Infect. Dis. J. 2009;28:S50–S53. doi: 10.1097/INF.0b013e3181967bee. - DOI - PubMed
    1. Rotavirus. [(accessed on 26 June 2017)]; Available online: http://www.who.int/immunization/diseases/rotavirus/en/

Publication types

LinkOut - more resources